eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2011
vol. 7
 
Share:
Share:

Case report
Myocardial infarction complicated by acute heart failure treated with percutaneous coronary intervention by transradial approach

Romuald Krynicki
,
Agnieszka Sobocińska

Post Kardiol Interw 2011; 7, 1 (23): 95-100
Online publish date: 2011/04/08
Article file
Get citation
 
 

Introduction

The early phase of an acute coronary syndrome may be a dramatic stage of coronary artery disease due to the risk of sudden death or acute heart failure [1]. It is known that prompt opening of the occluded infarct-related artery is the best method of treatment in prophylaxis of these complications [2, 3]. There are no controversies over the treatment of typical forms of myocardial infarction, but atypical infarctions may pose management challenges even for an experienced physician [1]. We describe a case of a patient with myocardial infarction complicated by pulmonary oedema and cardiogenic shock treated with primary percutaneous coronary intervention (PCI) with a transradial approach (TR).

Case report

A 74-year-old man was admitted to the Department of Cardiology on 19 March 2010 at 1:55 PM after several hours of resting dyspnoea which occurred without apparent reason. He reported limitation of exercise capacity (NYHA III) since 3-4 days previously. He had a history of left internal and external iliac artery angioplasty with bare metal stent implantation in 2008.

On admission to the ward the patient presented with pulmonary oedema, forced half-sitting position, BP 130/80 mmHg, HR 100-110 bpm and silent heart tones. La­bo­ratory tests revealed the following abnormalities: Na – 135.4 mmol/l (136.0-145.0), D-dimers – 2.33 µg FEU/ml (< 0.5), fibrinogen – 446 mg/dl (150-400), proBNP – 20230 pg/ml (< 300 pg/ml), troponin I – 0.91 ng/ml (cut-off point for myocardial infarction 0.9).

Blood morphology, potassium, creatinine, glucose plasma levels and INR were normal. ECG showed sinus rhythm 106 bpm, right bundle branch block and left posterior hemiblock, ST-segment elevation in leads V1-V3, ST-segment depression in leads V5-V6, Q wave in leads V2-V3 (fig. 1).

Echocardiography disclosed extensive left ventricular contraction abnormalities including akinesis of the periapical anterior and septal segments. Left ventricular ejection fraction (EF) was 20%.

The patient received aspirin – 75 mg p.o., clopidogrel – 300 mg p.o., enoxaparin – 0.6 ml s.c., nitroglycerine infusion with BP monitoring, 1 vial of furosemide i.v., 2.5 mg of morphine i.v. and oxygen.

Despite treatment the patient’s condition did not improve. Troponin I level assessed at 7 PM was 2.3 ng/ml.

Because of the dynamic rise of troponin I a decision to perform coronary angiography was made. The study was done at 10:30 PM of the same day using a left transradial approach and 6F catheters because of the patient’s inability to remain for long in the horizontal position (due to dyspnoea and half-sitting position).

Coronary angiography (fig. 2) showed significant stenosis close to the ostium of the right coronary artery (RCA), significant stenosis (70%) of the ostium of the left anterior descending artery (LAD) and critical stenosis in the proximal one third of the same vessel (secondary recanalization?) accompanied by critical stenosis in the proximal segment of the circumflex artery (Cx). Integrilin (Eptifibatide?) infusion was started according to the treatment scheme with the intention to perform PCI [4].

During coronary angiography the patient’s condition deteriorated: dyspnoea worsened, there was a blood pres­sure drop to 70/50 mmHg and tachycardia (130-140 bpm). An intra-aortic balloon pump (IABP) was installed through the transfemoral approach (TF) which resulted in BP and HR stabilization at 100/70 mmHg and 100-110 bpm after several minutes and significant reduction of dyspnoea.

Because of the fairly easy intubation of all coronary artery ostia with the use of catheters introduced through transradial access we decided to perform PCI of all lesions with this approach.

The circumflex artery was predilated using the Sequent balloon, 2.0 × 20 mm (16 atm), before implantation of the Coroflex Blue stent, 3.0 × 8 mm (18 atm). The distal lesion in the LAD was predilated using Sequent balloons, 1.5 × 20 mm (20 atm) and 2.0 × 20 mm (18 atm), before implantation of the Coroflex Blue stent, 2.5 × 16 mm (20 atm), and subsequent overlapping implantation of the Liberte stent, 3.0 × 8 mm (18 atm), proximally. The next step consisted of direct Liberte stent implantation (3.0 × 12 mm, 20 atm) into the RCA. The lesion in the ostium of the LAD was left without intervention (fig. 3).

A total of 300 ml of contrast agent (Iomeron 350) was used during the procedure. Total time of fluoroscopy was 33 min and 24 sec.

Peak concentration of troponin I was observed on the second day after PCI (52.80 ng/ml). The intra-aortic balloon pump was removed on day 3 after the procedure.

Chest X-ray performed on day 4 of the hospitalization showed a hyperintense pulmonary stromal picture with overlapping post-inflammatory interstitial densities in the subclavian and apical area of the right lung. Heart silhouette was normal.

Echocardiography performed on day 6 after the PCI procedure revealed improvement of the global left ventricular contractility and ejection fraction of 25-30%.

The patient was discharged home after 7 days of treatment with diagnosis of NSTEMI complicated by heart failure in the acute phase of myocardial infarction. On the day of discharge he was in NYHA heart failure class II and was instructed to return for another hospitalization after 3 months to qualify for eventual coronary artery bypass grafting of the lesion located in the LAD ostium.

Ambulatory therapy included: aspirin 75 mg/d, clopidogrel 75 mg/d, ramipril 2.5 mg/d, atorvastatin 40 mg/d and furosemide 20 mg/d. Because of the tendency for bradycardia (50-60 bpm) and low blood pressure (BP 100-90/70-50 mmHg) no beta-blocker was introduced.

After 3 months the pharmacotherapy was modified by addition of carvedilol 2 × 3.125 mg/d with the intention to increase the dose after 2-3 weeks. The patient remains under ambulatory monitoring and has exercise tolerance in NYHA class II. There was no change in the echo­cardiographic picture. He reports no complaints and has no desire for further invasive procedures (CABG, PCI).

Discussion

This case report deserves attention for several reasons. First, it is an example of a patient who presented with clinical symptoms of marked heart failure for several days without typical angina. The initial level of troponin I which was within the normal range also suggested aggravation of chronic heart failure (high values of pro-BNP).

Presence of Q wave and ST-segment elevation in the precordial ECG leads [5, 6] together with a low level of troponin and long lasting history of dyspnoea was suggestive of previous myocardial infarction. This concept was supported by the fact that ECG did not change significantly during subsequent days of hospitalization. Angiography of the LAD and difficulties in crossing the critical lesion with balloons were suggestive of secondary recanalization of the LAD after previous myocardial infarction. Based on the coronary angiography picture it was concluded that the present deterioration of circulatory capacity was caused by a critical lesion in the circumflex artery.

Secondly, the decision to perform coronary angiography in a patient with borderline values of troponin and developing pulmonary oedema was extremely difficult as administration of the contrast agent may additionally worsen the patient’s condition. At the same time it is known that isolated pulmonary oedema may be a reason for increase of markers of myocardial necrosis [7, 8].

Third, PCI using the transradial approach although more risky due to technical difficulties should be considered in patients with acute coronary syndromes, as reported by many researchers [9-12]. Hetherington SL et al., who analysed a group of more than one thousand patients with ST-segment elevation myocardial infarction (STEMI) without haemodynamic instability treated with PCI through a TR or TF approach, concluded that both methods are safe, but the transradial approach is related to lower risk of vascular complications [13].

If in our case the coronary angiography picture had not given a possibility to perform PCI (insignificant stenoses of the coronary arteries vs. atherosclerosis with no option for PCI) then the transfemoral approach and forced horizontal position after the procedure would have caused a major problem for the anaesthesiologists. The transradial approach does not limit the patient’s mobility or his body position, which can facilitate pharmacological treatment of pulmonary oedema by putting the patient in a sitting or half-sitting position.

It seems that coronary angiography and PCI through the transradial approach are not well promoted in our country despite the fact that for many reasons this method is superior to the traditional transfemoral approach [14-17] and is becoming a strongly propagated technique of coronary angiography in many centres despite longer radiation times in some cases [18]. Even PCI procedures presented at haemodynamic congresses and conferences are almost always performed via the transfemoral approach. Is this because of old habits?

In the literature there are no reports on PCI procedures performed through the transradial approach in haemo­dynamically compromised patients with ACS, although at the same time many authors think that this method is equally safe and effective in the treatment of uncom­plicated myocardial infarction as the transfemoral approach with lower risk of local complications after arterial puncture. The transfemoral approach seems more appro­priate when a second arterial approach is needed [10].

An important problem in the transradial approach is a low diameter of the radial artery and not infrequent artery spasm at the puncture site which occurs more often in women [15, 19].

The transradial approach can be achieved through right or left radial artery puncture. We prefer left radial artery access, because this way of introducing catheters to the ostia of coronary arteries resembles the curvature of catheter introduction through the femoral artery, which enables the use of typical diagnostic and guiding catheters.

Another problem is related to the dose and order of introduction into therapy of beta-blockers and angiotensin-converting enzyme inhibitors (ACEI), especially in patients with haemodynamically unstable heart failure, as observed in this case. We decided to use the highest possible dose of ACEI in the hospital phase with a plan to introduce beta-blockers in the period of the next several weeks.

According to the current guidelines for the mana­gement of coronary artery disease the presented picture of changes in coronary arteries and a relatively stable phase of the disease together with direct access to cardiac surgery would be an indication for coronary artery bypass grafting [5], which was not fulfilled in our case (the Department of Cardiac Surgery is located 80 km away from our centre). Therefore we decided to perform a maximally extensive PCI procedure to increase the patient’s chances of survival.

At the end of the discussion it is important to underline the value of periodic repeated sampling of blood for troponin in patients with suspected ACS, especially in those with atypical clinical presentation. Our experience shows that the diagnosis and treatment is not certain until repeated marker levels are known.

References

 1. Opolski G, Filipiak K, Poloński L (eds.). Ostre zespoły wieńcowe. Urban & Partner 2002; 33-34.  

2. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation 2008; 117: 296-329.  

3. Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Inter­ventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-847.  

4. Karvouni E, Katritsis DG, Ioannidis JPA. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. J Am Coll Cardiol 2003; 41: 26-32.  

5. Karpiński G, Opolski G, Filipiak KJ, Grabowski M. Strategia podejścia do pacjenta z ostrym zespołem wieńcowym. Przew Lek 2003; 6: 16-23.  

6. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2007; 50: 2173-2195.  

7. Mueller C. Risk stratyfication in acute decompensated heart failure: the role of cardiac troponin. Nat Clin Pract Cardiovasc Med 2008; 5: 680-681.  

8. Peacock WF, De Marco T, Fonarow GC, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008; 358: 2117-2126.  

9. Delarche N, Idir M, Estrade G, et al. Direct angioplasty for acute myocardial infarction in elderly patients using transradial approach. Am J Geriatr Cardiol 1999; 8: 32-35.

10. Kim MH, Cha KS, Kim HJ, et al. Primary stenting for acute myocardial infarction via the transradial approach: a safe and useful alternative to the transfemoral approach. J Invasive Cardiol 2000; 12: 292-296.

11. Ruzsa Z, Ungi I, Horvath T, et al. Five-year experience with transradial coronary angioplasty in ST-segment-elevation myocardial infarction. Cardiovasc Revasc Med 2009; 10: 73-79.

12. Valsecchi O, Musumeci G, Vassileva A, et al. Safety, feasibility and efficacy of transradial primary angioplasty in patients with acute myocardial infarction. Ital Heart J 2003; 4: 329-334.

13. Hetherington SL, Adam Z, Morley R, et al. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral artery. Heart 2009; 95: 1612-1618.

14. Amoroso G, Limbruno U, Petronio AS, et al. Safety, feasibility and six-month outcomes of a systematic strategy of direct coronary stenting by a transradial approach in patients with single-vessel disease. Ital Heart J 2004; 5: 22-28.

15. Bagger H, Kristensen JH, Christensen PD, et al. Routine transradial coronary angiography in unselected patients. J Invasive Cardiol 2005; 17: 139-141.

16. Galli M, Di Tano G, Mameli S, et al. Ad hoc transradial coronary angioplasty strategy: experience and results in a single centre. Int J Cardiol 2003; 92: 275-280.

17. Kośmider M. Koronarografia i zabiegi angioplastyki wieńcowej z dostępu przez tętnicę promieniową. Post Kardiol Interw 2006; 2: 139-141.

18. Philippe F, Larrazet F, Meziane T, et al. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab. Catheter Cardiovasc Interv 2004; 61: 67-73.

19. Majewski M, Lipiecki J, Link R, et al. Koronarografia z dostępu przez tętnicę promieniową. Znaczenie krzywej uczenia. Post Kardiol Interw 2006; 2: 185-188.
Copyright: © 2011 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.